21 May 2009
The influence of cyclosporine a and rapamycin on the b cell subpopulations in vitro
P Wierzbicki, M Jastrzębska, D Kłosowska, A Korecka, G Korczak-Kowalska, A GórskiAnn Transplant 2009; 14(1): 69-69 :: ID: 880452
Abstract
Background: Data on the influence of immunosuppressive drugs on the generation and functions of the B cell subpopulations including B-1a, B1b, and conventional B2 are limited. B1 cells are important cell population producing natural antibodies and involved in antibacterial humoral responses. Among them B1a subset expresses the pan-T cell surface glycoprotein CD5. This molecule is known to modulate lymphocyte activation and differentiation processes. Compared to B2 cells, B1a are long-lived, non-circulating, with reduced BCR affinity.
Material/Methods: The aim of this study was to compare the effects of two
commonly used immunosuppressive drugs, i.e. cyclosporine A (a calcineurine inhibitor) and rapamycin (a cell division inhibitor), on the induction of the B cell subpopulations. Mononuclear cells were obtained from the whole peripheral blood of healthy blood donors. PBMCs were cultured for five days in the presence or absence of either drug. Then the percentages of CD19, CD11b, and CD5 positive cells on PWM-activated and non-activated cells were determined using appropriate monoclonal antibodies. Flow cytometry was performed with a FACSCalibur (BD Biosciences) and data were analyzed using Cell Quest software.
Results: Although both investigated drugs decreased the percentages of B-1a and B1b cells, the difference was statistically significant only in the B-1a subpopulation. On the other hand, neither drug affected the percentage of B2 cells.
Conclusions: The present study is preliminary and we intend to pursue this
line of research by evaluating the influence of immunosuppressive drugs on the functions of the major B cell subpopulations, especially their capability to produce antibodies.
Keywords: Immunosuppression
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860